[PMID: 3961819] PubMed record related to this compound for laboratory literature review
Microbes in gastrointestinal health and disease
AmJ Clin Nutr, 1980;33(5):p.989 -97
Food and Drug Administration (FDA) has approved Eli Lilly and Company's ZepboundTM (tirzepatide) injection, marking it as the first and only obesity treatment that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Bitter Melon (Momordica charantia) A staple in many traditional medicine systems, bitter melon contains compounds that may encourage GLP-1 release and help the body maintain healthy blood sugar metabolism
Tissue-repair research more broadly has produced cross-compound findings, with multiple groups having investigated, characterised, and documented the four molecules across overlapping injury models